Alkem Labs Plant clears USFDA inspection
“USFDA had conducted an inspection at the company’s bioequivalence facility located at Taloja from July 10 to July 14, 2017”, Alkem Laboratories said in a filing to BSE.
“United States Food and Drug Administration ( USFDA) had conducted an inspection at the company’s bioequivalence facility located at Taloja from July 10 to July 14, 2017”, Alkem Laboratories said in a filing to BSE.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.